Literature DB >> 9730228

Isoxazolo-[3,4-d]-pyridazin-7-(6H)-ones and their corresponding 4,5-disubstituted-3-(2H)-pyridazinone analogues as new substrates for alpha1-adrenoceptor selective antagonists: synthesis, modeling, and binding studies.

F Montesano1, D Barlocco, V Dal Piaz, A Leonardi, E Poggesi, F Fanelli, P G De Benedetti.   

Abstract

A series of phenylpiperazinylalkyl moieties were attached to monocyclic or bicyclic substituted pyridazinones and the new compounds tested for their affinity towards alpha1-adrenoceptor and its alpha1a, alpha1b and alpha1d subtypes, as well as serotonin 5-HT1A receptor. Several analogues (5, 6, 9, and 10) showed remarkable potency and selectivity towards alpha1a, and alpha1d with respect to alpha1b subtype. None of the test compounds exhibited significant affinity for 5-HT1A receptor. Finally, on the basis of the alpha1-AR subtypes 3D models recently proposed, we have elaborated theoretical interaction models for the new compounds. The theoretical study allowed us to predict the affinity of the new compounds as well as to infer the structural/dynamics determinants of their interaction with the three alpha1-AR subtypes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9730228     DOI: 10.1016/s0968-0896(98)00056-x

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

1.  Microwave accelerated synthesis of isoxazole hydrazide inhibitors of the system xc- transporter: Initial homology model.

Authors:  Afnan A Matti; Joseph Mirzaei; John Rudolph; Stephen A Smith; Jayme L Newell; Sarjubhai A Patel; Michael R Braden; Richard J Bridges; Nicholas R Natale
Journal:  Bioorg Med Chem Lett       Date:  2013-08-27       Impact factor: 2.823

2.  Isoxazole analogues bind the system xc- transporter: structure-activity relationship and pharmacophore model.

Authors:  Sarjubhai A Patel; Trideep Rajale; Erin O'Brien; David J Burkhart; Jared K Nelson; Brendan Twamley; Alex Blumenfeld; Monika I Szabon-Watola; John M Gerdes; Richard J Bridges; Nicholas R Natale
Journal:  Bioorg Med Chem       Date:  2009-11-10       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.